“In MDD, insomnia symptoms exacerbate the risk of ... Spravato grew more than 80% to reach $689 million worldwide. The market for antidepressants is, however, getting more competitive after ...
Antidepressants and cognitive behavioral ... Behavioral activation, aggression, worsening depression, anxiety, insomnia, or impulsivity can herald a switch to mania or suicidality.
Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.
Both drugs were given on top of standard antidepressants to patients wo had failed a least two earlier treatments. Spravato has been approved since 2019 for TRD, with its label extended the ...
Now a sub-study shows that there is also ... Sleeping for 2: Insomnia Therapy Reduces Postpartum Depression, Study Shows Oct. 31, 2024 — CBT for insomnia significantly reduces postpartum ...